OCTOBIDPublic Tender GazetteThe Therapeutic Role of Soluble Adenylyl Cyclase Inhibition in Ameliorating Inflammatory Vascular Remodeling in Pulmonary Arterial Hypertension
Special Notice monitored from sam-gov.
- Buyer / agency
- HEALTH AND HUMAN SERVICES, DEPARTMENT OF
- Notice type
- Special Notice
- Solicitation number
- 75N98026R00085
- Posted
- September 13, 2026
- Response deadline
- September 21, 2026
- Location
- IL, US
- Estimated value
- Not published by the source
- NAICS
- 541715
- Source
- sam-gov
Summary
The National Institutes of Health (NIH) intends to negotiate on a sole-source basis with the University of Illinois at Chicago (UIC) for preclinical animal research services to evaluate the therapeutic effects of soluble adenylyl cyclase (sAC) inhibition on pulmonary arterial hypertension (PAH) using an established endothelial cell-specific Cav1 knockout (EC-Cav1 KO) murine model and corresponding wild-type controls. The Government intends to solicit from a single source purs…
See the official source link, all documents, and the full solicitation text — and prepare a proposal working draft with AI — with a free Octobid account.
Summaries are indexed from official public sources; the issuing platform’s notice, documents, and amendments always control.